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Abstract
Targeting allosteric sites is gaining increasing recognition as a strategy for modulating the activity of enzymes, especially in
drug design. Here we investigate the mechanisms of allosteric regulation of cathepsin K as a representative of cysteine
cathepsins and a promising drug target for the treatment of osteoporosis. Eight novel modifiers are identified by
computational targeting of predicted allosteric sites on the surface of the enzyme. All act via hyperbolic kinetic mechanisms
in presence of low molecular mass substrates, as expected for allosteric effectors. Two compounds have sizable effects on
enzyme activity using interstitial collagen as a natural substrate of cathepsin K and four compounds show a significantly
stabilizing effect on cathepsin K. The concept of activity modification space is introduced to obtain a global perspective of
the effects elicited by the modifiers. Analysis of the activity modification space reveals that the activity of cathepsin K is
regulated via multiple, different allosteric mechanisms.
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Introduction
The classical two-state conformational model proposed by
Monod and co-workers to explain allosteric interactions in
hemoglobin [1,2] has been expanded in recent years as a more
generalized mechanism of protein regulation than proposed
originally. Major extensions to the theory include allosteric
regulation of monomeric proteins and the not necessary presence
of distinctive conformational changes as a prerequisite for this type
of regulation [3,4].
Cysteine cathepsins belong to the papain-like peptidases and
constitute one of the major groups of lysosomal enzymes. They are
involved in diverse physiological and pathological processes and
have long been thought to be regulated primarily by macromo-
lecular active-site directed inhibitors (recently reviewed in ref. [2]).
Alternative mechanisms of regulation operate without direct
involvement of the active site. Glycosaminoglycans emerged as a
group of regulators with diverse effects on various cysteine
cathepsins, including the archetypal papain and lysosomal
cathepsin B [5,6]. The best studied example of this mode of
regulation is cathepsin K, the principal peptidase in bone turnover
and a promising target for the treatment of osteoporosis (reviewed
in ref. [7]). Its unique collagenolytic activity was shown to be
potentiated by cartilage-resident glycosaminoglycans, foremost
chondroitin sulfate [8,9]. Together with the crystal structure of
chondroitin sulfate bound to cathepsin K outside of the active site
[10], chondroitin sulfate and other sulfated glycosaminoglycans
have been characterized as the first allosteric regulators of a
papain-like peptidase [11].
Recently, we described the first low-molecular mass allosteric
modifier of cathepsin K identified by in silico screening of
compound libraries [12] targeted at predicted allosteric sites that
are connected to the active site via an evolutionarily conserved
network of residues, called a protein sector [13]. Here, we expand
the characterization of cathepsin K control by describing eight
further compounds that affect enzyme activity by mechanisms
that, kinetically, correspond to allosteric interactions. We exten-
sively characterize the described compounds and compare their
relative effects on cathepsin K by representing their activity by a
novel approach termed enzyme activity modification space.
Results
Identification of modifiers
The prediction of seven putative allosteric sites on cathepsin K
and targeting of these sites have been described previously [12].
Here, the same procedure was used to identify further allosteric
modifiers. Each predicted site was targeted in silico, as described
in more detail in the Materials and Methods section. The
approach included a first round of high-throughput docking of
compound libraries using UCSF Dock 6, followed by a second
round in which the top 10% of hits were re-docked to the same site
with AutoDock. Altogether, over 200 compounds were selected for
experimental evaluation. Eight novel modifiers of cathepsin K are
described herein. Their structures are shown in Figure 1A and
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Figure 1. Structures, predicted binding sites and docked poses of the identified modifiers. (A) Structural formulas of the identified
modifiers. (B) The locations of six potential allosteric sites on cathepsin K targeted in this study. Binding sites for each modifier marked. For reference,
the location of the active site is marked by an arrow. (C) Binding poses of identified binders at their target sites on cathepsin K. In both panels, the
receptor is shown in surface representation and colored according to the electrostatic potential (the colorbar is shown in the inset in panel A and is
given in dimensionless units calculated by APBS) and the compounds are shown as sticks. The shown binding poses were calculated with AutoDock.
Images was created with PyMOL (Schro¨dinger, Inc., Portland, OR, USA). Abbreviation: CPD – compound.
doi:10.1371/journal.pone.0106642.g001
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further information on their identity and origin is given in Table 1.
Each compound was predicted to bind to two of six different sites
on cathepsin K (Figure 1B). The lowest energy binding modes
calculated with AutoDock are shown in Figure 1C and the
corresponding binding energies and equilibrium dissociation
constants are collected in Table 2. The seventh putative allosteric
site on the bottom of the molecule is not shown in Figure 1B since
none of the compounds were predicted to bind there.
Cathepsin K is known for its high positive charge at about half
of its molecular surface (Figure 1B) and electrostatic interactions
are key to its regulation by glycosaminoglycans [10]. Charge-
charge interactions are apparently also important in small
molecule binding, as each of the identified modifiers contains at
least one ionizable group (Figure 1A). The predicted binding sites
are diverse both in shape and electrostatic potential. Whereas sites
5 and 6 are located in the positively charged area, sites 1 and 4
represent negatively charged patches on the protein’s surface and
the potential of sites 2 and 3 is near-neutral. Sites 1 and 2 were
each bound by compounds 2 and 5 which both contain amino
groups that can interact favorably with the slightly negative or
near-neutral electrostatic potential of these sites. Sites 3 and 4 were
bound by compounds 1, 6 and 8. At site 4, interactions were again
driven by electrostatic interactions between the negatively charged
enzyme surface and amino groups of the ligands. Interestingly, site
3 has the shape of a deep narrow groove and thus appears as a
typical small molecule-binding site. However, none of the
predicted compounds bound within the narrow groove. Instead,
interactions are limited to the region surrounding the cleft. Finally,
sites 5 and 6 were bound by compounds 3, 4 and 7 which contain
carboxyl groups that interact with positively charged surface
residues on the enzyme. These two sites were also predicted
previously as binding sites for the allosteric modifier NSC13345
and site 6 was revealed as the true binding site [12].
Determination of kinetic mechanisms
All modifiers were tested for their effect on the hydrolysis of the
low molecular mass synthetic substrate Z-FRQAMC. Since all
progress curves were linear from the beginning of the reaction,
initial velocities were calculated from the slopes by linear
regression. No significant deviations from linearity were observed
for the first 120 s of the reaction and no substrate inhibition was
apparent at the substrate concentrations used in this study. The
basic mechanism considered for the analysis of the interactions
was the general modifier mechanism shown in Figure 2, in which
the effect of modifier is determined by the values of the coefficients
a and b that multiply the kinetic parameters KS, KA (a) and kcat (b)
[14]. In the thermodynamic box embodied in Figure 2, the
reciprocal of the coefficient a represents the allosteric coupling
constant that characterizes energy linkage between the modifier
and the substrate [15], while a non-zero value of b represents the
effect exerted by the modifier on catalysis. The specific velocity
plot [16] was used for the primary screening of the kinetic
behavior of the modifiers (Equation 2), as it allows an immediate
judgment of the type of interaction and to gather preliminary
estimates of the coefficients a and b, as well as of the dissociation
constant of the modifier. Refinement was then performed by
fitting the rate Equation 1 to data.
Specific velocity plots for all modifiers are shown in Figure 3
along with relative velocity versus modifier concentration curves
recorded at fixed substrate concentrations. The kinetic parameters
calculated from the combinations of both methods are collected in
Table 3, together with activity parameters determined from other
assays described in the next section. The calculated equilibrium
dissociation constants of the enzyme/modifier complex KA were in
the 1025 to 1023 molar range, which was expected considering the
size of the compounds and the fact that they were selected without
optimization of the binding geometry. All eight modifiers acted by
a hyperbolic mechanism, i.e. they caused a reduction of the
reaction rate without driving it to zero at saturation. They can be
subdivided into four groups according to their mechanisms of
modification as determined from combinations of the coefficients a
and b in Figure 2. Compounds 1 through 3 were assigned to a first
group with characteristic values of a.1 and b,1, which can thus
be classified as hyperbolic mixed, predominantly competitive
inhibitors. Compounds 1 and 2 had large values of a, indicating a
strong competitive component, whereas that of compound 3 was
only slightly above 1, a property that accounts for the different
behavior of compound 3 with respect to compounds 1 and 2 in
assays described in the following subsections. The second group
comprised the pair of compounds 4 and 5, which belong to a class
of hyperbolic mixed modifiers with a dual behavior as inhibitors or
activators depending on substrate concentration and characterized
by values of a and b both larger than 1 and a.b. This rare
mechanism, observed previously in the case of compound
NSC13345 [12], is characterized by a critical substrate concen-
tration, which in terms of the [S]/Km ratio s, can be defined as
s0 = (b–a)/(1–b). Actually, this calculation is based on the [S]/Ks
ratio that, in virtue of the quasi-equilibrium assumption made with
the use of the specific velocity plot, is approximated to [S]/Km. At
substrate concentrations that give [S]/Km smaller than s
0 these
compounds behave as inhibitors, while at substrate concentrations
giving [S]/Km larger than s
0 they behave as activators. If the
substrate concentration is such that [S]/Km = s
0, no effect is
observed. Compound 6, which is the only representative of the
Table 1. Modifiers used in this work.
Identifier IUPAC name Supplier (Cat. No.)
Compound 1 3-Amino-4-[(tetrahydro-2-furanylmethyl)amino] benzoic acid Chembridge Corp. (7607879)
Compound 2 Piperidin-2-yl-[2-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]pyridin-4-yl] methanol The NCI/DTP Open Chemical Repository (NSC305798)
Compound 3 N-Benzoyl-p-aminosalicylic acid The NCI/DTP Open Chemical Repository (NSC159686)
Compound 4 (2-Biphenylylmethyl) malonic acid The NCI/DTP Open Chemical Repository (NSC94914)
Compound 5 1, 4, 7, 9B-Tetraazaphenalene The NCI/DTP Open Chemical Repository (NSC81462)
Compound 6 1-[1-(2-Phenylethyl)-4-piperidinyl]-methanamine Chembridge Corp. (4009651)
Compound 7 2-[(3-Nitrophenyl)carbamoyl]benzoic acid The NCI/DTP Open Chemical Repository (NSC408860)
Compound 8 Methyl N-[1-(4-methoxyphenyl)-2,5-dioxopyrrolidin-3-yl]glycinate Chembridge Corp. (5855661)
doi:10.1371/journal.pone.0106642.t001
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third group, behaved as a hyperbolic competitive inhibitor in
which the ESA complex is turned over with the same catalytic
constant as the ES complex (b= 1). The fourth group contains a
pair of hyperbolic mixed inhibitors with uncompetitive character,
compounds 7 and 8, which differ from the other groups for their
values of a and b being less than 1. Kinetic experiments with these
two compounds were the most erratic in the series investigated.
With a.b the mechanism is classified as hyperbolic mixed,
predominantly uncompetitive inhibition, while with a= b the
mechanism is called hyperbolic uncompetitive inhibition. In the
former case, the sheaf of straight lines in the specific velocity plot
should intersect the ordinate at 1 and the abscissa at a negative
value. In the second case, the lines should intersect at ordinate 1
and abscissa 0. The best-fit results from the relative velocity versus
modifier concentration plots shown in Figure 3 point to a= b. It
remains established that, for this type of modifiers, inhibitory
efficiency increases with increasing substrate concentration.
Inhibition of macromolecular substrate hydrolysis
The use of synthetic substrates is practical for the determination
of the mechanisms of modification. However, these results do not
necessarily represent the effect of modifiers on the hydrolysis of
macromolecular substrates. Therefore, all modifiers were also
tested with two macromolecular substrates, calf skin collagen and
azocasein. The collagenolytic activity was tested quantitatively by
following the fragmentation of the characteristic type I collagen
pattern into smaller products on SDS-PAGE after incubation of
the samples with cathepsin K in the presence and absence of
modifiers. Of the eight modifiers, only compounds 1 and 2 showed
a concentration-dependent inhibitory effect (Figure 4A), whereas
no inhibitory, or activating, activity was observed for the
remaining six compounds. IC50 values were estimated at around
1 mM and 0.5 mM for compounds 1 and 2, respectively.
Similarly, all compounds showed little or no inhibitory activity
in azocasein degradation assays (Figure 4B). Compounds 1
through 6 reduced the activity of cathepsin K by less than 25
percent with compounds 1 and 6 being the most effective, while
compounds 7 and 8 were ineffective. Due to the generally small
inhibitory effects, IC50 values could be reliably determined only for
the two most effective compounds. The calculated IC50 value for
compound 1 was 7306190 mM and was thus comparable to the
value estimated for the degradation of collagen. The calculated
IC50 value for compound 6 was 11006240 mM. Thus, IC50 was
about 4-fold higher than KA for both compounds.
For the needs of the activity space analysis presented in one of
the following subsections, azocasein degradation assays were also
performed in the presence of glycosaminoglycans and clusterin
(Figure 4C). Two different concentrations of glycosaminoglycans
were used (10 mg/ml and 200 mg/ml, respectively) to take into
account the varying concentration-dependent effects of glycos-
aminoglycans in collagen degradation assays [17]. In all cases,
glycosaminoglycans behaved as inhibitors, except the lowest
concentration of chondroitin sulfate was ineffective. A marginal
inhibitory effect was also observed for clusterin.
Stabilization of cathepsin K at physiological plasma pH
Apart from directly affecting the activity of their target,
allosteric modifiers have the potential to affect other aspects of
enzymatic activity, such as its stability under unfavorable
conditions. In the case of cathepsin K, heparin and the
extracellular chaperone clusterin have been shown to increase
the stability of the otherwise unstable peptidase at the physiological
plasma pH value of 7.4 [11,18]. The instability of cathepsin K has
been shown to be due at least partly to autoproteolytic degradation
[11]. Therefore, allosteric modifiers can contribute to the
stabilization of the enzyme by at least two mechanisms, i.e. by
inhibiting its proteolytic activity or by shielding the susceptible
regions of the molecule from proteolytic attack by directly binding
to these regions.
Table 2. Binding energies and equilibrium dissociation constants calculated by AutoDock.
Modifier Target site1 Estimated free energy of binding2 (kcal/mol) Estimated equilibrium dissociation constant3 (mM)
Compound 1 Site 3 25.98 42
Site 4 28.24 0.9
Compound 2 Site 1 26.44 19
Site 2 25.52 90
Compound 3 Site 5 26.73 12
Site 6 25.49 95
Compound 4 Site 5 26.42 20
Site 6 26.33 23
Compound 5 Site 1 28.59 0.5
Site 2 25.95 43
Compound 6 Site 3 26.78 11
Site 4 27.18 5.0
Compound 7 Site 5 27.52 3.0
Site 6 28.05 1.3
Compound 8 Site 3 26.28 25
Site 4 24.33 670
1All sites are number according to Figure 1B.
2Corresponding to the lowest energy binding modes shown in Figure 1C.
3Output by AutoDock as estimated ‘‘inhibition’’ constant calculated from the estimated free energy of binding at 298.15 K.
doi:10.1371/journal.pone.0106642.t002
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Here we have examined the newly identified modifiers for their
effect on the stability of cathepsin K. As shown in Table 4,
compounds 1, 2 and 5 increased the stability of cathepsin K by
about 2-fold, which is similar to the activation effect produced by
clusterin [18]. The remaining compounds were less efficient. For
the needs of the activity modification space analysis, the
experiment was also performed with the previously described
allosteric modifier NSC1335. This compound showed a weak
stabilization effect, increasing the half-life of cathepsin K by 1.2-
fold. Altogether, no clear correlation between their stabilizing
effect and other kinetic or activity parameters can be determined
for the modifiers. It is hence likely that their overall effects on
enzyme stability are due to a combination of multiple factors, as
discussed above.
The activity modification space of cathepsin K
The enzyme activity modification space is a straightforward
method to combine results from different experiments and globally
compare the effects of different modifiers on an enzyme. We define
it as an n-dimensional space, where n is equal to the number of
different experimentally determined parameters presented in the
particular representation. Parameters can be plotted either in
terms of thermodynamic constants, values of coefficients such as a
and b in the general modifier mechanism, or relative activities.
Depending on the number of dimensions, data can be plotted
directly or the dimensions reduced by calculating the principal
components of the activity space matrix and plotting the first two
or three components. In general, the activity modification space
can be viewed as a part of the complete enzyme activity space
which represents all possible activity profiles of a particular
enzyme, caused not only by modifiers which bind the enzyme in a
defined manner, but also by other environmental parameters, such
as ionic strength, pH, temperature, etc.
Here the activity modification space concept is used in two
independent ways to investigate the effects of all known modifiers
of cathepsin K other than active-site directed inhibitors. Data for
previously known modifiers was taken either from published
sources or from experiments performed specifically for this
purpose, as described in the previous subsections. First, a simple
two-dimensional representation was constructed only from the
values of the kinetic coefficients a and b determined for the
modifiers when using the synthetic substrate Z-FRQAMC
(Figure 5A), the most commonly used substrate for measuring
the activity of cathepsin K and other cysteine cathepsin
endopeptidases in vitro. This representation shows that cathepsin
K can be affected by all types of hyperbolic mechanisms
determined by the general modifier mechanism, including
inhibition, activation and mixed inhibition/activation mecha-
nisms, as discussed in more detail above. The distinctively colored
parts of the a/b diagram represent the combinations of both
coefficients that produce different types of allosteric modification,
i.e. mixed inhibition, mixed inhibition/activation or non-essential
activation. Hyperbolic competitive inhibitors are defined by a
combination of a.1 and b= 1, whereas uncompetitive inhibitors
are defined by the combination 0,a= b,1. By definition, no
allosteric modification is possible at a= 1 due to the absence of
thermodynamic coupling between modifier and substrate [15]. A
special case is represented by the point (1,1) where both
coefficients a and b are equal to 1. A modifier with this
combination of parameters binds to the enzyme without any
measurable effect on its activity under the particular experimental
conditions. One example is the recently described compound
NSC13345. While the compound had no significant effect on the
hydrolysis of Z-FRQAMC, other experiments have clearly shown
that the compound binds and inhibits the enzyme [12]. Another
class of compounds with this particular combination of coefficients
are so-called liberators, represented by the recently described
clusterin [18]. Again, no effect on enzymatic activity is observed in
the ternary ESA complex. However, in the presence of an
inhibitor, the liberator negates the effect of the inhibitor and thus
‘‘liberates’’ the enzyme [19]. The representation in Figure 5A also
takes into account all linear mechanisms of inhibition which lie on
the abscissa (b= 0). They are discriminated among each other by
their respective values of the coefficient a. For linear competitive
inhibitors the value of a approaches ‘. Despite their absence from
the representation in Figure 5A a number of such inhibitors have
been described for cathepsin K, including endogenous macromo-
lecular inhibitors as well as a plethora of active site-directed
reversible inhibitors designed for cathepsin K targeting in medical
applications (reviewed in ref. [7]). For linear uncompetitive
inhibitors, a?0, while linear mixed inhibitors are characterized
by values of a.1. Finally, the mostly theoretical non-competitive
mechanism would be characterized by the value of a= 1 and
b= 0.
The approach in Figure 5A summarizes the kinetic parameters
and thereby aids in identifying and categorizing the kinetic
mechanisms by which cathepsin K activity can be modified. It is,
however, suitable only for data obtained with synthetic substrates,
which allow for the determination of the individual coefficients. To
evaluate comprehensively the effect of the modifiers on cathepsin
K we have utilized four different assays described above, where
each assay investigates a different aspect of modifier activity. The
overall potency of the modifiers, and their categorization, rely on
the combined effects of each modifier across all performed assays.
For a global analysis, data from all four experiments was collected
in the form of an activity modification matrix (Table S1) and
analyzed by principal component analysis [20]. A plot of the first
three principal components which account for more than 90% of
the variance are shown in Figure 5B. In general, the distance of
each modifier from the position of enzyme alone can be
interpreted as a measure of the strength of modification.
Analogously, characteristic groups formed in the activity modifi-
cation space can be interpreted as distinctive modes of enzyme
modification. The modifiers investigated in the present study are
divided into two groups. The first group is formed by the pair of
compounds 1 and 2, which act as inhibitors in all performed assays
and stabilize the enzyme at neutral pH. The remaining
Figure 2. Reaction scheme for the general modifier mechanism.
The scheme describes the interaction of enzyme (E) with substrate (S)
and modifier (A). KS and KA are equilibrium dissociation constants of the
ES and EA complexes under rapid equilibrium conditions, kcat is the
catalytic constant and a and b are dimensionless coefficients that
determine the effect of modifier on the substrate-binding affinity of the
enzyme and the catalytic rate, respectively.
doi:10.1371/journal.pone.0106642.g002
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Figure 3. Kinetic mechanisms of the identified modifiers. All compounds were characterized by a combination of specific velocity plots (upper
panels) and titration curves recorded at fixed substrate concentrations (lower panels). The kinetic parameters calculated from the combination of
both methods are given in Table 3. All experiments were performed at 2561uC in 100 mM sodium acetate buffer pH 5.50 containing 1 mM EDTA
and 2.5 mM DTT using the fluorogenic substrate Z-FRQAMC and at a final enzyme concentration of 0.5 nM.
doi:10.1371/journal.pone.0106642.g003
Table 3. Kinetic and other activity parameters of the identified modifiers.
Substrate Z-FRQAMC Azocasein Calf skin collagen
a1 b1 KA (mM) Residual activity (in %) IC50 (mM)
2
Compound 1 6.763.0 0.5560.25 190620 7469 1000
Compound 2 7.260.5 0.7460.13 150650 9367 500
Compound 3 1.760.5 0.4460.22 110620 8664 n.i.
Compound 4 5.661.2 1.560.3 100640 9063 n.i.
Compound 5 4.861.5 1.560.2 2065 8664 n.i.
Compound 6 3.060.2 1 270650 7768 n.i.
Compound 7 0.1960.03 0.1960.03 290620 10465 n.i.
Compound 8 0.3160.06 0.3160.06 11006200 10163 n.i.
1Coefficients a and b multiply the kinetic parameters KS, KA (a) and kcat (b) and thus quantify the effect of modifier on the affinity for the substrate (a) and the catalytic
rate (b), respectively.
2n.i. indicates no inhibition.
doi:10.1371/journal.pone.0106642.t003
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Figure 4. Effect of modifiers on the degradation of macromolecular substrates. (A) Effect of increasing concentrations of compounds 1 and
2 on the degradation of calf skin collagen. Molecular mass standards are given in kDa and positions of a, b and c chains of intact collagen are marked
by arrows. (B) Effect of modifiers on azocasein degradation. (C) Effect of glycosaminoglycans and clusterin on azocasein degradation. Two different
concentrations of each glycosaminoglycan were used in the experiments (10 mg/ml and 200 mg/ml). Error bars in panels B and C represent the SEM of
three experiments. All experiments were performed in 100 mM sodium acetate buffer pH 5.50 containing 1 mM EDTA and 5 mM DTT, as described in
detail in the Materials and Methods section. Abbreviations: CPD – compound, CS – chondroitin sulfate, DS – dermatan sulfate, HP – heparin.
doi:10.1371/journal.pone.0106642.g004
Table 4. Effect of modifiers on the stability of cathepsin K at pH 7.4.
Modifier Half-life (min)
enzyme only 6.461.2
Compound 1 13.562.6
Compound 2 14.360.7
Compound 3 8.660.9
Compound 4 9.560.8
Compound 5 13.660.7
Compound 6 7.561.1
Compound 7 10.161.8
Compound 8 6.561.0
NSC13345 7.760.7
The enzyme was incubated at 37uC in 50 mM Hepes buffer pH 7.40 containing 1 mM EDTA and 5 mM DTT in the presence or absence of each modifier. Aliquots were
withdrawn from the reaction mixtures at regular time intervals and their residual activity measured using the substrate Z-FRQAMC.
doi:10.1371/journal.pone.0106642.t004
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Figure 5. Activity modification space of cathepsin K. (A) The repertoire of binding affinities (parameter a) and catalytic rates (parameter b) with
Z-FRQAMC as substrate. Areas of the modification space that represent distinctive modes of modification are marked accordingly. Since heparin (HP)
binds to two sites on cathepsin K, data for each site are presented separately in this representation. The image was created with GraphPad Prism 5.0.
(B) The global effect of all known modifiers of cathepsin K other than active site-directed competitive inhibitors was analyzed with principal
component analysis. Data is presented as a three-dimensional diagram of the first three principal components, which account for more than 90% of
the variance. The analysis was performed on an activity modification matrix containing data collected from all four types of assays described herein
(Table S1). Vertical lines in the diagram indicate the positions of each modifier in the plane defined by principal components 1 and 2. Color-coding
corresponds to the division of the modifiers into different groups, based on the results of this analysis. Modifiers identified in this study are marked
with consecutively increasing Arabic numerals according to Table 1. The position of cathepsin K alone is marked by ‘‘0’’ The image was created with
Matlab. Abbreviations: CS – chondroitin sulfate, DS – dermatan sulfate, HP – heparin, CLU – clusterin.
doi:10.1371/journal.pone.0106642.g005
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compounds form a loose group located in the vicinity of
unmodified cathepsin K, reflecting their overall weak effect on
cathepsin K. Of the previously known modifiers, NSC13345 and
glycosaminoglycans, each form distinctive groups in the activity
modification space distant from the position of unmodified
enzyme. Not surprisingly, a significant degree of dispersion is
observed in the glycosaminoglycan group (chondroitin sulfate,
dermatan sulfate and heparin), resulting from their diverse effects
on cathepsin K described herein and previously [11]. Last,
clusterin is positioned close to unmodified cathepsin K due to its
lack of effect on enzyme activity and can be considered part of the
cluster formed by compounds 3 through 8.
Discussion
The primary goal of this study was to investigate the range of
effects that can be produced by allosteric modifiers of cathepsin K.
The theory of enzyme kinetics does not set precise limitations in
terms of the effects on substrate binding affinity or catalytic rate of
any enzyme. However, the activity of enzymes is restricted by their
structural limitations meaning that each enzyme can exhibit only a
limited range of kinetic profiles, which can result either from its
intrinsic flexibility or from the binding of an allosteric modifier.
The concept of activity modification space was introduced to
globally analyze the effect of the identified modifiers on cathepsin
K. This method is similar to the concepts of ligand-activity space
(or substrate-activity space) which uses a multidimensional
representation to analyze the directed evolution of enzymes using
multiple different substrates or ligands (see ref. [21] and refs.
therein) and chemical space of inhibitors which was recently used
to investigate the selectivity of PARP inhibitors [22].
Results obtained with the eight modifiers described in this paper
and previous findings show that cathepsin K has a broad activity
space and that it is very sensitive to modification by specific
mechanisms, such as binding of modifier, as well as non-specific
mechanisms, such as variations in the ionic strength of the medium
[11]. At the structural level, this is probably related to a high
structural flexibility of the molecule, which can be easily explained
by its broad specificity for macromolecular proteinaceous
substrates. The analysis of the activity modification space
(Figure 5) identified several functionally distinct groups of com-
pounds, indicating the presence of multiple allosteric mechanisms
in the molecule. Glycosaminoglycans and NSC13345 each formed
clearly distinguishable groups within the activity space related to
their distinctive allosteric mechanisms of action, which have been
characterized both structurally and functionally [10,11,12]. The
newly identified modifiers are separated from these two groups
indicating that they are functionally distinct. These compounds
either bind to allosteric sites elsewhere on the molecule or they
elicit different allosteric responses by binding to the same site on
the enzyme. The latter was observed in several systems, e.g. the
conformational changes associated with GTP and GDP binding to
G proteins such as Ras and cAMP-dependent protein kinase
(discussed in ref. [23]). The compounds form two groups in the
activity modification space, one is formed by compounds 1 and 2
which exhibit the overall strongest performance in activity and
stability assays, whereas the remaining compounds form a group
that is closely located near unmodified cathepsin K, reflecting their
overall weak activity. Given the diverse kinetic profiles and
structural diversity of the latter group, these compounds are likely
to bind to several different binding sites that do not efficiently
transmit allosteric signals through the molecule. A comparison of
computationally predicted and experimentally determined equi-
librium constants (Tables 2 and 3, respectively) shows that for all
compounds except 6 and 7 at least one of the predicted sites
remains a viable candidate for the true binding site. Minor
differences between both values can be easily accounted for by
receptor flexibility, as observed in the case of NSC13345 where
the experimentally determined binding constant was 5-fold lower
than the computationally predicted value [12]. While the
compounds 1 and 2 are commendable of further development
for drug design, the remaining six are interesting not only for their
in vitro kinetic effects, but also for the development of specific
probes to follow cathepsin K activity in vivo. Currently available
probes bind into the active site of their targets and thereby abolish
the target’s activity, binding at a distant site would, however, allow
to follow the enzyme in action.
In general, the distinguishable groups in the activity space
identify several trends of activity modification. The inhibitory
effect of NSC13345 scales proportionally with substrate size,
ranging from no interaction with Z-FRQAMC to full inhibition
with collagen [12], whereas the inverse trend is observed for
compounds 3 through 6. Glycosaminoglycans and compounds 1
and 2 show no clear trends in this respect, however, modifier
activity is again dependent on the substrate. Finally, clusterin
provides additional diversity by acting as a liberator without
affecting enzyme activity per se. While the plethora of different
effects may seem erratic, it is a clear indication that allosteric
mechanisms serve to fine-tune the activity of papain-like pepti-
dases in nature, while emergency inhibition is reserved for
macromolecular inhibitors.
Materials and Methods
Materials
Recombinant human cathepsin K was prepared as described
previously [24]. Chemical probes were obtained from the U.S.
NCI/DTP Open Chemical Repository or from ChemBridge
(USA). Information on their identity and origin is given in
Table 1. All compounds were soluble in aqueous buffers at
concentrations of at least 2 mM, except for compound 2, which
was soluble up to a maximal concentration of 1 mM. Stock
solutions of all compounds were prepared in DMSO. The
fluorogenic substrate Z-FRQAMC (benzyloxycarbonyl-Phe-Arg-
7-amino-4-methylcoumarin) was from Bachem (Switzerland).
Docking of compound libraries
Potential allosteric modifiers were predicted as described
previously [12]. In short, the NCI Diversity Set III and Chem-
Bridge Building Blocks compound libraries were obtained from
the ZINC database [25] and filtered to retain only molecules with
molecular masses between 150 and 500 Da and less than seven
rotatable bonds. Both libraries were docked to all seven predicted
allosteric sites on cathepsin K [12]. Cathepsin K coordinates were
retrieved from the Protein Data Bank (PDB ID 1ATK). Docking
was first performed with the UCSF Dock 6.4 program suite
(available online at http://dock.compbio.ucsf.edu/) using default
values of all parameters. The best hits (about top 10%) were
selected based on the binding energies calculated by the internal
scoring function and re-docked to the receptor using AutoDock
4.2 [26]. The best binders were again selected on the basis of the
binding affinities calculated by the AutoDock internal scoring
function. Each ligand was parameterized to allow the maximum
number of rotatable bonds, but excluding amide and ring bonds.
Docking was performed with the Lamarckian genetic algorithm.
For each ligand, 20 runs were performed using a population of 300
individuals over 3000 generations, starting from random orienta-
tions and conformations. For presentation of the results, the lowest
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energy poses calculated by AutoDock were selected and visualized
with PyMOL. The receptor surface was colored according to its
electrostatic potential calculated with APBS [27].
Kinetic measurements
All kinetic measurements were performed in 100 mM sodium
acetate buffer pH 5.50 containing 1 mM EDTA and 2.5 mM
dithiothreitol (DTT) in single-use acrylic cuvettes (161 cm)
thermostatted at 2561uC with magnetic stirring. The hydrolysis
of Z-FRQAMC was followed fluorometrically at lex 383 nm and
lem 455 nm. All tested modifiers were analyzed spectroscopically
to determine their absorption properties under the conditions used
in the assays. When necessary, appropriate corrections were made
to the calculated reaction rates to take into account the inner filter
effect [28].
Kinetic model
The effects of the modifiers on enzymatic activity were analyzed
with the general modifier mechanism [14] which describes the
interaction between enzyme (E), substrate (S) and modifier (A), as
shown in Figure 2. Assuming that binding of A to E and ES is at
quasi-equilibrium and that steady-state conditions are established
in the fluxes around ES and ESA (i.e. the catalytic steps), the
reaction rate for the mechanism in Figure 2 is defined by Equation
1:
vA~
v0 1zsð Þ 1zb A½ 
aKA
 
1z
A½ 
KA
zs 1z
A½ 
aKA
  ð1Þ
where v0 is the reaction rate in the absence of modifier, KA is the
equilibrium dissociation constant of the EA complex, a and b are
dimensionless coefficients and s= [S]/Km, approximated to [S]/
Ks. To determine the mechanism of interaction, plot the kinetic
data and calculate preliminary values of the interaction param-
eters, the specific velocity plot was used [16]. For this purpose,
Equation 1 is rewritten as:
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The plot of v0/vA versus s/(1+s) produces straight lines with
intersection points at v0/vA = 1, regardless of the interaction
mechanism. The parameters a, b and KA are determined by
replotting the extrapolated values of the straight lines at s/(1+
s) = 0 (a) and s/(1+s) = 1 (b) versus 1/[A] in the form:
a
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Collagenolytic assays
Soluble calf skin collagen (Worthington Biochemical Corpora-
tion, USA) was diluted in 100 mM sodium acetate buffer pH 5.50
containing 1 mM EDTA and 5 mM DTT to a final concentration
of 0.5 mg/ml. Experiments were started by addition of cathepsin
K (final enzyme concentration 0.6 mM) to the reaction mixture
containing collagen and increasing concentrations of modifier. All
assays were performed at 28uC with shaking on an Eppendorf
Thermomixer Comfort. Samples were incubated for 2 hours and
the reactions then blocked by addition of E-64 to a final
concentration of 1 mM. 10 mg of digested collagen were analyzed
by SDS-PAGE on 8% polyacrylamide gels and protein bands
visualized by Coomassie Brilliant Blue R-250 staining.
Azocasein degradation assays
Azocasein (Sigma-Aldrich, USA) was dissolved in 100 mM
sodium acetate buffer pH 5.50 containing 1 mM EDTA and
5 mM DTT at a concentration of 3 mg/ml. Samples were
incubated with 0.1 mM cathepsin K for 30 min at 37uC in the
presence of each compound. All compounds were used at
concentrations increasing up to 2 mM, except compound 2,
which was used at a maximal concentration of 1 mM due to its
limited solubility at higher concentrations. Reactions were stopped
by addition of trichloroacetic acid (final concentration 5% v/v),
centrifuged, clear supernatants mixed with 0.5 M NaOH and the
concentrations of solubilized peptides determined by measuring
the absorbance at 440 nm. All experiments were performed in
triplicates and appropriate blanks were run to take into account
the absorption of azocasein and compounds alone. IC50 values
were determined as described previously [12].
Thermal stability of cathepsin K in the presence of
modifiers
Cathepsin K was incubated at 37uC in 50 mM Hepes buffer
pH 7.40 containing 1 mM EDTA and 5 mM DTT in the
presence or absence of each modifier. The final enzyme
concentration was 0.2 mM and final compounds concentrations
were 2 mM, except compound 2, which was used at a
concentration of 1 mM. All experiments were performed in
Eppendorf Protein LoBind Tubes to minimize the adsorption of
proteins on tube walls. Aliquots were withdrawn from the reaction
mixtures at regular time intervals and their residual activity
measured using the substrate Z-FRQAMC (5 mM final concen-
tration). Inactivation curves had exponential profiles that were
fitted with the mathematical model for one-phase exponential
decay to determine the half-life of the enzyme in each reaction
mixture.
Principal component analysis of the activity modification
space
For analysis, the results of each experiment were presented as
one data set termed the activity modification matrix (Table S1).
Data from experiments performed with the synthetic substrate Z-
FRQAMC was included as the geometric mean of residual
activities (vA) at a low substrate concentration (0.16Km) and a high
substrate concentration (106Km), both in the presence of a
saturating modifier concentration (106KA). For each modifier,
Equation 1 was used to calculate the appropriate values of vA
using experimentally determined values of the parameters a and b.
Stabilization of the enzyme was expressed as ln(sf), where the
stabilization factor sf is the ratio of half-lives determined in the
presence and absence of modifier. Azocasein degradation data was
input as the fraction of residual enzyme activity (a value of 1 equals
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the activity of unmodified enzyme). For collagenolytic assays,
qualitative values of 1 and 0 were used to signify inhibition and
lack thereof, respectively. For glycosaminoglycans, a value of 21
was used to signify their concentration- and environment-
dependent activation/inhibition activity. Principal component
calculations and graphical visualizations were performed in the
Matlab environment.
Supporting Information
Table S1 The activity modification matrix used for
principal component analysis.
(PDF)
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